OCC 0.00% 36.0¢ orthocell limited

Ann: Final Data Readout for Orthocells Nerve Reconstruction Study, page-40

  1. 757 Posts.
    lightbulb Created with Sketch. 120
    I just believe the connections and knowledge he has would be hard to replace. I think he would be good behind the scenes. Get a good proactive MD to dtive the products into the market place. Without Paul there wouldn't be an orthocell and they are progressing. Ive been on companies with much worse and the reverse, they got so far in front of themselves tripped up. Over the next couple of years progress to date means pieces of the jigsaw puzzle could quickly fall in to place and we could progress quite fast.

    I am also unsure what it means with them presenting ati results at the TOBI conference, does this mean jnj are not interested? Is ati dead in the water?
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
(20min delay)
Last
36.0¢
Change
0.000(0.00%)
Mkt cap ! $75.35M
Open High Low Value Volume
35.5¢ 36.0¢ 35.5¢ $51.60K 145.1K

Buyers (Bids)

No. Vol. Price($)
3 145099 35.5¢
 

Sellers (Offers)

Price($) Vol. No.
36.0¢ 131882 2
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.